Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BATS BZX Real-Time Price
As of 11:44am ET
 -0.05 / -1.08%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 9.00. The median estimate represents a +118.34% increase from the last price of 4.58.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -9.38%
Growthannually -880.77%


Growthquarterly -100.00%
Growthannually -99.90%
Key to the earnings and sales forecast charts.